Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL1374769 | 0.71 | CA4 (0.78) | CA4FAHD1CA1 | |
| Oxalic Acid SCHEMBL4606657 | 0.71 | — | — | |
| Oxalic Acid SCHEMBL18298182 | 0.67 | CA4 (0.70) | CA4FAHD1CA1 | |
| Oxalic Acid SCHEMBL18298178 | 0.67 | CA4 (0.70) | CA4FAHD1CA1 | |
| Oxalic Acid SCHEMBL6018199 | 0.66 | CA4 (0.88) | CA4FAHD1CA1 | |
| Oxalic Acid SCHEMBL9879794 | 0.66 | CA4 (0.88) | CA4FAHD1CA1 | |
| Oxalic Acid SCHEMBL50017 | 0.66 | — | — | |
| Oxalic Acid SCHEMBL29078419 | 0.63 | — | — | |
| Oxalic Acid SCHEMBL22129976 | 0.63 | — | — | |
| Oxalic Acid SCHEMBL11140409 | 0.63 | CA4 (0.64) | CA4FAHD1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169947-B2 | Dicopper(I) oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLISCHAFT (DE) | 2007-01-30 | — | — | US | claimed |
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | US | claimed |
| US-7169947-B2 | Dicopper(I) oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLISCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | AOC1, PDXK, OAT | CA4 852/4885FAHD1 3621/4885CA1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.